Occurrence of MRSA endocarditis during linezolid treatment.
Ben Mansour
E H
EH
Department of General Intensive Care, University Hospital, Domaine universitaire du Sart-Tilman, 4000 Liege, Belgium.
Jacob
E
E
Monchi
M
M
Ledoux
D
D
Canivet
J-L
JL
De Mol
P
P
Damas
P
P
D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications / Q000188:drug therapy*; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000627:therapeutic use*; D018570:Risk Assessment; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid